365542-01-4

Basic information

• Product Name: 2-Oxazolidinone, 3-[(2S)-2-(hydroxymethyl)-3-methyl-1-oxobutyl]-4-(phenylmethyl)-, (4R)-
• CAS NO: 365542-01-4
• Molecular Formula: C16H21NO4
• Molecular Weight: 291.347
• Mol File: 365542-01-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 2-Oxazolidinone, 3-[(2S)-2-(hydroxymethyl)-3-methyl-1-oxobutyl]-4-(phenylmethyl)-, (4R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Oxazolidinone, 3-[(2S)-2-(hydroxymethyl)-3-methyl-1-oxobutyl]-4-(phenylmethyl)-, (4R)-(365542-01-4)
• EPA Substance Registry System: 2-Oxazolidinone, 3-[(2S)-2-(hydroxymethyl)-3-methyl-1-oxobutyl]-4-(phenylmethyl)-, (4R)-(365542-01-4)

Safety Data

• Hazardous Substances Data: 365542-01-4(Hazardous Substances Data)

Upstream product

• 108-12-3 isopentanoyl chloride 
• 365541-74-8 (4R)-3-{(2S)-3-methyl-1-oxo-2-[(phenylmethoxy)methyl]butyl}-4-(phenylmethyl)oxazolidin-2-one 
• 40217-17-2 (R)-4-(phenylmethyl)-2-oxazolidinone 
• 110-88-3 1,3,5-Trioxan 
• 145589-03-3 (R)-4-benzyl-3-(3-methylbutyryl)oxazolidin-2-one 

Downstream Products

• 880870-09-7 (R)-4-benzyl-3-((S)-2-((methoxymethoxy)methyl)-3-methylbutanoyl)oxazolidin-2-one 
• 424822-01-5 4(R)-benzyl-3-(2(R)-chlorosulfonylmethyl-3-methylbutyryl)oxazolidin-2-one 
• 365541-75-9 (2R)-3-methyl-2-[(phenylmethoxy)methyl]butan-1-ol 
• 365541-76-0 (2S)-2-(benzyloxy)methyl-3-methyl-1-butanal 
• 424821-99-8 4(R)-benzyl-3-(2(R)-acetylthiomethyl-3-methylbutyryl)oxazolidin-2-one 
• 424822-00-4 4(R)-benzyl-3-(2(R)-iodomethyl-3-methylbutyryl)oxazolidin-2-one 

Relevant articles and documents

The convergent synthesis of novel cytotoxic certonardosterol D2 from diosgenin

Certonardosterol D2, a polyhydroxysterol isolated from starfish Certonardoa semiregularis with exceptionally potent antitumor activity, was stereoselectively synthesized from natural rich diosgenin via the protocol of Julia olefination and Evan

HYDROXAMATE SULFONAMIDES AS CD23 SHEDDING INHIBITORS

A class of piperidine and related heterocyclic derivatives, C-substituted by a substituted aryl or heteroaryl moiety, and N-substituted by an ethylsulfonyl group which in turn is substituted at the 2-position by a hydroxamic acid moiety and also by a range of alternative substituents, being potent inhibitors of CD23 shedding, are useful in the treatment and/or prevention of allergic, inflammatory and neoplastic diseases.

An enantioselective synthesis of sulphonamide hydroxamic acids as matrix metalloproteinase inhibitors

A high yielding and enantioselective synthesis of α-substituted hydroxamic acids as inhibitors of matrix metalloproteinases is described.